MON-LB102 Metformin-Induced Weight Loss in Patients With or Without Type 2 Diabetes/Prediabetes

Background: Metformin is the first-line pharmacologic treatment for type 2 diabetes (T2DM). Its use has been associated with significant weight loss in patients with obesity with or without T2DM. However, it is unknown whether weight loss outcomes differ with metformin monotherapy in patients with e...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Endocr Soc
Main Authors: Chukir, Tariq, Mandel, Lindsay, Al-Mulla, Nada, Kumar, Rekha Babu, Igel, Leon I, Waitman, Jonathan, Aronne, Louis J, Shukla, Alpana P
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2020
Teme:
Adipose Tissue, Appetite, and Obesity
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7208508/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvaa046.2084
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki